Biophytis (EPA:ALBPS) | WebDisclosure

REGULATED PRESS RELEASE

published on 07/22/2024 at 07:00, 1 year 8 months ago

Biophytis déploie sa stratégie de partenariats et signe deux contrats avec des agents locaux en Asie
Biophytis annonce le déploiement de sa stratégie de partenariats en Asie en signant deux contrats avec des agents locaux pour BIO101 afin d'accélérer son développement sur les marchés clés comme le Japon et la Chine

Biophytis Partenariats Asie Contrats BIO101
REGULATED PRESS RELEASE

published on 07/22/2024 at 07:00, 1 year 8 months ago

Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
Biophytis implements partnership strategy in Asia with new contracts to advance drug candidate BIO101 in Japan, South Korea, China, and Southeast Asia

Biophytis Asia Contracts Partnership Strategy Drug Candidate BIO101
BRIEF

published on 07/11/2024 at 08:18, 1 year 8 months ago

Biophytis Obtains IND Approval from FDA for Phase 2 Obesity Study

Biophytis FDA Approval Phase 2 Clinical Trial BIO101 Obesity Study
BRIEF

published on 07/11/2024 at 08:18, 1 year 8 months ago

Biophytis obtient l'approbation IND de la FDA pour une étude de phase 2 sur l'obésité

Biophytis Approbation De La FDA Essai Clinique De Phase 2 BIO101 Étude Sur L'obésité
PRESS RELEASE

published on 07/11/2024 at 08:13, 1 year 8 months ago

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis receives FDA IND approval for phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by renowned expert Marc-André Cornier

FDA Biophytis Obesity IND Approval OBA Study
PRESS RELEASE

published on 07/11/2024 at 08:13, 1 year 8 months ago

Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité
Biophytis obtient l'autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l'obésité. L'étude vise à mesurer l'amélioration de la force musculaire et la composition corporelle

FDA Biophytis Obésité Autorisation IND Étude OBA
BRIEF

published on 07/11/2024 at 07:06, 1 year 8 months ago

Biophytis obtient l’autorisation IND de la FDA pour une étude de phase 2 dans l’obésité

FDA Biophytis Étude Clinique BIO101 Obésité
BRIEF

published on 07/11/2024 at 07:06, 1 year 8 months ago

Biophytis Receives FDA IND Approval for Phase 2 Obesity Study

Biophytis FDA Approval Phase 2 Study BIO101 Obesity
REGULATED PRESS RELEASE

published on 07/11/2024 at 07:01, 1 year 8 months ago

Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité
Biophytis obtient l'autorisation IND de la FDA pour lancer l'étude OBA de phase 2 dans l'obésité avec BIO101 (20-hydroxyecdysone), visant à améliorer la force musculaire. Le professeur Marc-André Cornier dirigera l'étude multicentrique aux Etats-Unis

Biophytis BIO101 Obésité Autorisation IND Étude OBA
REGULATED PRESS RELEASE

published on 07/11/2024 at 07:01, 1 year 8 months ago

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA

Biophytis FDA Approval Obesity Treatment BIO101 Phase 2 OBA Study

Published on 03/24/2026 at 18:55, 2 hours 57 minutes ago

Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 8 hours 22 minutes ago

GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 8 hours 22 minutes ago

Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 9 hours 17 minutes ago

Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 9 hours 19 minutes ago

Mako Mining Completes Acquisition of Mt. Hamilton in Nevada

View all ACCESSWIRE

Published on 03/24/2026 at 21:08, 44 minutes ago

Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Published on 03/24/2026 at 19:49, 2 hours 3 minutes ago

EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 2 hours 10 minutes ago

ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 2 hours 47 minutes ago

WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 3 hours 12 minutes ago

EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026

View all EQS

Published on 03/24/2026 at 18:21, 3 hours 31 minutes ago

Résultats annuels 2025
Published on 03/24/2026 at 18:21, 3 hours 31 minutes ago

2025 Annual results
Published on 03/24/2026 at 18:00, 3 hours 52 minutes ago

i2S : Résultats annuels 2025
Published on 03/24/2026 at 17:46, 4 hours 6 minutes ago

NRJ GROUP - Avis résultats annuels 2025
Published on 03/24/2026 at 17:46, 4 hours 6 minutes ago

NRJ GROUP - Press release annual results 2025

View all LES ECHOS COMFI WIRE

News